Improving equitable access and adherence to secondary Prevention therapy with a Fixed-Dose Combination Drug

Trial Profile

Improving equitable access and adherence to secondary Prevention therapy with a Fixed-Dose Combination Drug

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Aspirin/ramipril/simvastatin (Primary) ; Aspirin; Ramipril; Simvastatin
  • Indications Embolism and thrombosis; Myocardial infarction; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms FOCUS
  • Most Recent Events

    • 14 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 23 Jul 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 02 Jun 2012 Additional lead trial centre identified as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top